Rifamycin-induced lupus syndrome

Lancet. 1997 May 24;349(9064):1521-2. doi: 10.1016/S0140-6736(05)62102-2.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Anti-Bacterial Agents / adverse effects*
  • Antibiotics, Antitubercular / adverse effects
  • Antibodies, Antinuclear / analysis
  • Drug Interactions
  • Female
  • Humans
  • Lupus Erythematosus, Systemic / chemically induced*
  • Lupus Erythematosus, Systemic / immunology
  • Male
  • Middle Aged
  • Mycobacterium Infections / drug therapy
  • Rifabutin / adverse effects
  • Rifamycins / adverse effects*
  • Syndrome

Substances

  • Anti-Bacterial Agents
  • Antibiotics, Antitubercular
  • Antibodies, Antinuclear
  • Rifamycins
  • Rifabutin